ResearcherDalian Medical UniversityActive in the last 2 years
Dong Shang
Matched on ORCID iD 0000-0003-1030-916X; OpenAlex author ID A5101923466. Sources: OpenAlex.
Their work
- Papers
- 6 (first author 0, last author 3)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 24
2020: 2 papers · 2021: none · 2022: none · 2023: none · 2024: 2 papers · 2025: 1 paper · 2026: 1 paper
Papers 6
- Network toxicology and bioinformatics reveal potential molecular links between cadmium exposure and pancreatic cancer. Co-author DOI 10.1186/s40360-026-01156-6↗
- Determining a robust prognostic biomarker for 804 patients with pancreatic cancer using a machine learning computational framework. Last author DOI 10.1097/js9.0000000000002016↗
- Development of a Serum-Based MicroRNA Signature for Early Detection of Pancreatic Cancer: A Multicenter Cohort Study. Co-author DOI 10.1007/s10620-024-08338-4↗
- Prognostic and therapeutic value of the Eph/Ephrin signaling pathway in pancreatic cancer explored based on bioinformatics. Last author DOI 10.1038/s41598-024-68385-9↗
- Spatial-domain low-coherence quantitative phase microscopy to improve the cytological diagnosis of pancreatic cancer. Co-author DOI 10.1136/jim-2019-000997↗
- T Lymphocytes: A Promising Immunotherapeutic Target for Pancreatitis and Pancreatic Cancer? Last author DOI 10.3389/fonc.2020.00382↗
Closest collaborators
The 24 strongest of 24 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Qihang Yuan · 2 shared papers, 2024–2025 · strength 0.58
- Paper Determining a robust prognostic biomarker for 804 patients with pancreatic cancer using a machine learning computationa… DOI 10.1097/js9.0000000000002016↗
- Paper Prognostic and therapeutic value of the Eph/Ephrin signaling pathway in pancreatic cancer explored based on bioinformat… DOI 10.1038/s41598-024-68385-9↗
- Qingkai Zhang · 1 shared paper, 2026 · strength 0.30
- Shuyuan Liu · 1 shared paper, 2026 · strength 0.30
- Bing Qi · 1 shared paper, 2024 · strength 0.22
- Xu Chen · 1 shared paper, 2024 · strength 0.22
- Jifeng Liu · 1 shared paper, 2024 · strength 0.22
- Shuang Li · 1 shared paper, 2024 · strength 0.22
- Zhigang Zhang · 1 shared paper, 2024 · strength 0.16
- Yefu Liu · 1 shared paper, 2024 · strength 0.16
- Jianzhou Liu · 1 shared paper, 2024 · strength 0.16
- Yongwei Sun · 1 shared paper, 2024 · strength 0.16
- Jing Li Huang · 1 shared paper, 2024 · strength 0.16
- Minwei Yang · 1 shared paper, 2024 · strength 0.16
- Vay Liang W. Go · 1 shared paper, 2024 · strength 0.16
- Gary Guishan Xiao · 1 shared paper, 2024 · strength 0.16
- Junchao Guo · 1 shared paper, 2024 · strength 0.16
- Ge Gao · 1 shared paper, 2024 · strength 0.16
- Hongbin Ma · 1 shared paper, 2020 · strength 0.16
- Yang Liu · 1 shared paper, 2020 · strength 0.16
- Qi Zhou · 1 shared paper, 2020 · strength 0.13
- Hong Xiang · 1 shared paper, 2020 · strength 0.13
- Fangyue Guo · 1 shared paper, 2020 · strength 0.13
- Xufeng Tao · 1 shared paper, 2020 · strength 0.13
- Shilin Xia · 1 shared paper, 2020 · strength 0.13
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.